መነሻ › ሉኬሚያ › ካሊፎርኒያ › Los Angeles
በLos Angeles፣ CA ለሉኬሚያ የሚደረጉ ክሊኒካዊ ጥናቶች
ለሉኬሚያ የሚደረጉ 16 ጥናቶች በLos Angeles እና በአካባቢው ባሉ ቦታዎች (በወደ 30 ማይል ውስጥ) ተሳታፊዎችን እየፈለጉ ነው። ማን መሳተፍ እንደሚችል እና የጥናት ቡድኑን እንዴት መገናኘት እንደሚቻል ለማየት ጥናቱን ክፈቱ።
Official study text (English)
ለጥናት ተሳታፊዎችን እየፈለጉ ነው? በዚህ ገጽ ላይ በ$99 ለ30 ቀናት ያስቀምጡት →
Pivotal Open-label Phase 3 Clinical Study of QTX-2101 in Adult Patients With Acute Promyelocytic Leukemia
ተሳታዮችን በመፈለግ ላይደረጃ 3
- Quetzal Site 7, Los Angeles
Evaluation of Two Dose Levels of Quizartinib as Maintenance in FLT3-ITD (+) Acute Myeloid Leukemia Patients in Complete Remission
ተሳታዮችን በመፈለግ ላይደረጃ 2
- USC Norris Comprehensive Cancer Center, Los Angeles
(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis
ተሳታዮችን በመፈለግ ላይደረጃ 2
- UCLA Medical Center, Los Angeles
Cognitive Aftereffects of Neurotoxicity in Children and Young Adults With Relapsed/Refractory Hematologic Malignancies Who Receive CAR T-cell Therapy
ተሳታዮችን በመፈለግ ላይየመመልከት ጥናትጤናማ ተሳታዮች ይቀበላሉ
- Children s Hospital of Los Angeles, Los Angeles
Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML
ተሳታዮችን በመፈለግ ላይደረጃ 3
- Cedars-Sinai Medical Center, Los Angeles
- University of California, Los Angeles, Los Angeles
Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia
ተሳታዮችን በመፈለግ ላይደረጃ 1
- USC Norris Comprehensive Cancer Center, Los Angeles
- UCLA Health - Bowyer Oncology Center, Los Angeles
Caloric Restriction and Activity to Reduce Chemoresistance in B-ALL
ተሳታዮችን በመፈለግ ላይደረጃ 2
- Children's Hospital Los Angeles, Los Angeles
AZD0486 as Monotherapy in B-cell Acute Lymphoblastic Leukaemia
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
- Research Site, Los Angeles
Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
- Valkyrie Clinical Trials, Los Angeles
Duvelisib and Venetoclax in Patients With Relapsed or Refractory Peripheral T-cell Lymphoma (PTCL)
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
- David Geffen School of Medicine at the University of California at Los Angeles, Los Angeles
Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome
ተሳታዮችን በመፈለግ ላይደረጃ 2
- UCLA Department of Medicine, Los Angeles
A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)
ተሳታዮችን በመፈለግ ላይደረጃ 2/3
- Keck School of Medicine of USC, Los Angeles
The OPAL Study: AVM0703 for Treatment of Lymphoid Malignancies
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
- Los Angeles Cancer Network, Los Angeles
- UCLA Medical Center of Hematology/Oncology, Los Angeles
A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML
ተሳታዮችን በመፈለግ ላይደረጃ 1
- USC / Norris Comprehensive Cancer Center, Los Angeles
- UCLA - Bowyer Oncology Center, Los Angeles
A Study of BH-30236 in Relapsed/ Refractory Acute Myelogenous Leukemia and Higher Risk Myelodysplastic Syndrome
ተሳታዮችን በመፈለግ ላይደረጃ 1
- University of California Los Angeles, Los Angeles
Effects of Using a Storybook, to Explain Leukemia to Children Versus the Standard Child Life Intervention, on Parental Stress.
ተሳታዮችን በመፈለግ ላይጤናማ ተሳታዮች ይቀበላሉ
- Children's Hospital Los Angeles, Los Angeles
በሌሎች ከተሞች ለሉኬሚያ የሚደረጉ ጥናቶች
- Houston, TX28 ጥናቶች
- Boston, MA25 ጥናቶች
- New York City, NY19 ጥናቶች
- Chicago, IL16 ጥናቶች
- Durham, NC13 ጥናቶች
- Columbus, OH12 ጥናቶች
- Baldwin Park, CA12 ጥናቶች
- Nashville, TN12 ጥናቶች
- Philadelphia, PA12 ጥናቶች
- Milwaukee, WI11 ጥናቶች
- Atlanta, GA11 ጥናቶች
- Seattle, WA11 ጥናቶች
በLos Angeles ውስጥ ያሉ ሌሎች ጥናቶች
- ኖን-ስማል ሴል የሳንባ ካንሰር87 ጥናቶች
- ካንሰር (ሁሉም ዓይነቶች)73 ጥናቶች
- የጡንቻ ካንሰር72 ጥናቶች
- የፕሮስቴት ካንሰር61 ጥናቶች
- የኮሎሬክታል ካንሰር59 ጥናቶች
- Metastatic Cancer57 ጥናቶች
- የእንቁላል ካንሰር50 ጥናቶች
- የሳንባ ካንሰር45 ጥናቶች
- የራስ እና የአንገት ስኩዋመስ ሴል ካርሲኖማ42 ጥናቶች
- የፓንክሪያስ ካንሰር35 ጥናቶች
- የኤንዶሜትሪየም ካንሰር34 ጥናቶች
- ሜላኖማ34 ጥናቶች
ከ ClinicalTrials.gov የተገኘ መረጃ፣ በ5 ኦክቶ 2026 የተሰብሰቡ። እያንዳንዱ ጥናት የራሱን ቅድመ ሁኔታ ይወስናል፤ የጥናት ቡድኑ ማን መሳተፍ እንደሚችል ይወስናል።